Article Text
Abstract
In ‘Placebo treatments, informed consent, and “the grip of a false picture”’ Shane Nicholas Glackin argues that if a physician offers a patient an inert placebo with the following disclosure, this is compatible with informed consent and is not deceptive: ‘I would like to offer you a pill which I believe can help lessen your suffering. I do not know exactly how it works. I have other pills to offer whose mechanism is clearer, but I am not sure that they will work better for you, and they may also entail more serious side effects’. According to Glackin, telling patients that the recommended treatment is an inert placebo is providing incidental information, analogous to telling a patient the chemical details of an active drug. He argues that this information would influence a patient's decision only if she was ‘in the grip of a false picture’ that inert drugs do not have physical effects on patients’ bodies. We contend that this disclosure typically is incompatible with informed consent and typically is deceptive. We give an example of a transparent placebo disclosure, that is, a disclosure that is compatible with informed consent and is not deceptive.
- Informed Consent
- Autonomy
- Clinical Ethics
Statistics from Altmetric.com
Linked Articles
Read the full text or download the PDF:
Other content recommended for you
- Patients’ attitudes about the use of placebo treatments: telephone survey
- Physician perspectives on placebo ethics
- The ethics of the placebo in clinical practice revisited
- Parsing placebo treatments: a response to Barnhill and Miller
- Placebo: the lie that comes true?
- Patient attitudes about the clinical use of placebo: qualitative perspectives from a telephone survey
- Prescribing “placebo treatments”: results of national survey of US internists and rheumatologists
- What do we really know about the deliberate use of placebos in clinical practice?
- The moral case for the clinical placebo
- Informed consent and clinical trials: where is the placebo effect?